Updates
May 5, 2014
Changes Coming to Prescription Drug Advertising

On April 21, 2014, continuing its scrutiny of the disclosures of risks and benefits in prescription drug advertising, FDA announced a plan to conduct a study "designed to test different ways of measuring consumers' benefit and risk perceptions after exposure to direct-to-consumer (DTC) prescription drug advertising." 


Click here to view the full alert.